Cargando…
Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?
Antibiotics once regarded as magic bullets are no more considered so. Overuse of antibiotics in humans, agriculture, and animal husbandry has resulted in the emergence of a wide range of multidrug-resistant (MDR) pathogens which are difficult to treat. Antimicrobial resistance (AMR) is a serious glo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719572/ https://www.ncbi.nlm.nih.gov/pubmed/35071644 http://dx.doi.org/10.4103/jehp.jehp_557_21 |
_version_ | 1784624963601301504 |
---|---|
author | Sannathimmappa, Mohan Bilikallahalli Nambiar, Vinod Aravindakshan, Rajeev |
author_facet | Sannathimmappa, Mohan Bilikallahalli Nambiar, Vinod Aravindakshan, Rajeev |
author_sort | Sannathimmappa, Mohan Bilikallahalli |
collection | PubMed |
description | Antibiotics once regarded as magic bullets are no more considered so. Overuse of antibiotics in humans, agriculture, and animal husbandry has resulted in the emergence of a wide range of multidrug-resistant (MDR) pathogens which are difficult to treat. Antimicrobial resistance (AMR) is a serious global health problem associated with high mortality in the era of modern medicine. Moreover, in the absence of an effective antibiotic, medical and surgical interventions can highly become a risk. In recent times, the decreased incline of pharmaceutical industries toward research and development of newer effective antibiotics to fight this MDR pathogens have further fuelled the scarcity of antibiotics, thus the number of antibiotics in the pipeline is extremely limited. Hence it is high time for the development of new strategies to fight against dangerous MDR pathogens. Currently, several novel approaches explored by scientists have shown promising results pertaining to their antimicrobial activity against pathogens. In this article, the authors have summarized various novel therapeutic options explored to contain AMR with special attention to the mechanism of action, advantages, and disadvantages of different approaches. |
format | Online Article Text |
id | pubmed-8719572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-87195722022-01-20 Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? Sannathimmappa, Mohan Bilikallahalli Nambiar, Vinod Aravindakshan, Rajeev J Educ Health Promot Review Article Antibiotics once regarded as magic bullets are no more considered so. Overuse of antibiotics in humans, agriculture, and animal husbandry has resulted in the emergence of a wide range of multidrug-resistant (MDR) pathogens which are difficult to treat. Antimicrobial resistance (AMR) is a serious global health problem associated with high mortality in the era of modern medicine. Moreover, in the absence of an effective antibiotic, medical and surgical interventions can highly become a risk. In recent times, the decreased incline of pharmaceutical industries toward research and development of newer effective antibiotics to fight this MDR pathogens have further fuelled the scarcity of antibiotics, thus the number of antibiotics in the pipeline is extremely limited. Hence it is high time for the development of new strategies to fight against dangerous MDR pathogens. Currently, several novel approaches explored by scientists have shown promising results pertaining to their antimicrobial activity against pathogens. In this article, the authors have summarized various novel therapeutic options explored to contain AMR with special attention to the mechanism of action, advantages, and disadvantages of different approaches. Wolters Kluwer - Medknow 2021-11-30 /pmc/articles/PMC8719572/ /pubmed/35071644 http://dx.doi.org/10.4103/jehp.jehp_557_21 Text en Copyright: © 2021 Journal of Education and Health Promotion https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Sannathimmappa, Mohan Bilikallahalli Nambiar, Vinod Aravindakshan, Rajeev Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? |
title | Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? |
title_full | Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? |
title_fullStr | Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? |
title_full_unstemmed | Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? |
title_short | Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? |
title_sort | antibiotics at the crossroads – do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719572/ https://www.ncbi.nlm.nih.gov/pubmed/35071644 http://dx.doi.org/10.4103/jehp.jehp_557_21 |
work_keys_str_mv | AT sannathimmappamohanbilikallahalli antibioticsatthecrossroadsdowehaveanytherapeuticalternativestocontroltheemergenceandspreadofantimicrobialresistance AT nambiarvinod antibioticsatthecrossroadsdowehaveanytherapeuticalternativestocontroltheemergenceandspreadofantimicrobialresistance AT aravindakshanrajeev antibioticsatthecrossroadsdowehaveanytherapeuticalternativestocontroltheemergenceandspreadofantimicrobialresistance |